# Christopher J. Lindsell

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christopher-j-lindsell/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,273 |
| Field | Sepsis Diagnosis and Treatment |
| h-index | 81 |
| i10-index | 347 |
| Last Known Institution | Duke University |
| OpenAlex ID | https://openalex.org/A5006953289 |
| ORCID iD | 0000-0002-3297-2811 |
| Works | 635 |

## Researcher papers

Showing 12 of 15.

- [Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020](https://scholariq.org/papers/symptom-duration-and-risk-factors-for-delayed-return-to-usual-health-among/)
- [Balanced Crystalloids versus Saline in Noncritically Ill Adults](https://scholariq.org/papers/balanced-crystalloids-versus-saline-in-noncritically-ill-adults/)
- [Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study](https://scholariq.org/papers/clinical-severity-of-and-effectiveness-of-mrna-vaccines-against-covid-19-from/)
- [Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity](https://scholariq.org/papers/association-between-mrna-vaccination-and-covid-19-hospitalization-and-disease/)
- [Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c](https://scholariq.org/papers/red-cell-life-span-heterogeneity-in-hematologically-normal-people-is-sufficient/)
- [Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021](https://scholariq.org/papers/comparative-effectiveness-of-moderna-pfizer-biontech-and-janssen-johnson-and-amp/)
- [Recovery After Mild Traumatic Brain Injury in Patients Presenting to US Level I Trauma Centers](https://scholariq.org/papers/recovery-after-mild-traumatic-brain-injury-in-patients-presenting-to-us-level-i/)
- [Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19](https://scholariq.org/papers/effect-of-hydroxychloroquine-on-clinical-status-at-14-days-in-hospitalized/)
- [Functional Outcomes Over the First Year After Moderate to Severe Traumatic Brain Injury in the Prospective, Longitudinal TRACK-TBI Study](https://scholariq.org/papers/functional-outcomes-over-the-first-year-after-moderate-to-severe-traumatic-brain/)
- [Developing a Clinically Feasible Personalized Medicine Approach to Pediatric Septic Shock](https://scholariq.org/papers/developing-a-clinically-feasible-personalized-medicine-approach-to-pediatric/)
- [Risk of Posttraumatic Stress Disorder and Major Depression in Civilian Patients After Mild Traumatic Brain Injury](https://scholariq.org/papers/risk-of-posttraumatic-stress-disorder-and-major-depression-in-civilian-patients/)
- [Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study](https://scholariq.org/papers/association-between-plasma-gfap-concentrations-and-mri-abnormalities-in-patients/)

## Researcher topics

- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Trauma and Emergency Care Studies](https://scholariq.org/topics/trauma-and-emergency-care-studies/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Traumatic Brain Injury and Neurovascular Disturbances](https://scholariq.org/topics/traumatic-brain-injury-and-neurovascular-disturbances/)

## Researcher university

- [Duke University](https://scholariq.org/institutions/duke-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.